10-94545923-T-C
Position:
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 8P and 16B. PVS1BP6_Very_StrongBS1BS2
The NM_018063.5(HELLS):āc.2T>Cā(p.Met1?) variant causes a start lost change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000998 in 1,555,604 control chromosomes in the GnomAD database, including 13 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ā ).
Frequency
Genomes: š 0.0045 ( 6 hom., cov: 33)
Exomes š: 0.00062 ( 7 hom. )
Consequence
HELLS
NM_018063.5 start_lost
NM_018063.5 start_lost
Scores
2
4
9
Clinical Significance
Conservation
PhyloP100: 2.23
Genes affected
HELLS (HGNC:4861): (helicase, lymphoid specific) This gene encodes a lymphoid-specific helicase. Other helicases function in processes involving DNA strand separation, including replication, repair, recombination, and transcription. This protein is thought to be involved with cellular proliferation and may play a role in leukemogenesis. Alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Jan 2014]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -8 ACMG points.
PVS1
Start lost variant, no new inframe start found.
BP6
Variant 10-94545923-T-C is Benign according to our data. Variant chr10-94545923-T-C is described in ClinVar as [Likely_benign]. Clinvar id is 716400.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00447 (681/152318) while in subpopulation AFR AF= 0.0152 (633/41566). AF 95% confidence interval is 0.0142. There are 6 homozygotes in gnomad4. There are 319 alleles in male gnomad4 subpopulation. Median coverage is 33. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 6 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
HELLS | NM_018063.5 | c.2T>C | p.Met1? | start_lost | 1/22 | ENST00000348459.10 | NP_060533.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
HELLS | ENST00000348459.10 | c.2T>C | p.Met1? | start_lost | 1/22 | 1 | NM_018063.5 | ENSP00000239027.7 |
Frequencies
GnomAD3 genomes AF: 0.00448 AC: 682AN: 152200Hom.: 6 Cov.: 33
GnomAD3 genomes
AF:
AC:
682
AN:
152200
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00128 AC: 204AN: 159870Hom.: 1 AF XY: 0.00111 AC XY: 94AN XY: 84506
GnomAD3 exomes
AF:
AC:
204
AN:
159870
Hom.:
AF XY:
AC XY:
94
AN XY:
84506
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000621 AC: 871AN: 1403286Hom.: 7 Cov.: 31 AF XY: 0.000598 AC XY: 414AN XY: 692472
GnomAD4 exome
AF:
AC:
871
AN:
1403286
Hom.:
Cov.:
31
AF XY:
AC XY:
414
AN XY:
692472
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00447 AC: 681AN: 152318Hom.: 6 Cov.: 33 AF XY: 0.00428 AC XY: 319AN XY: 74484
GnomAD4 genome
AF:
AC:
681
AN:
152318
Hom.:
Cov.:
33
AF XY:
AC XY:
319
AN XY:
74484
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ESP6500AA
AF:
AC:
64
ESP6500EA
AF:
AC:
2
ExAC
AF:
AC:
140
Asia WGS
AF:
AC:
8
AN:
3478
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 02, 2024 | - - |
Immunodeficiency-centromeric instability-facial anomalies syndrome 4 Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Center for Genomics, Ann and Robert H. Lurie Children's Hospital of Chicago | Oct 05, 2022 | This variant has not been reported in the literature but is present in the Genome Aggregation Database (Highest reported MAF 1.5% (633/41444) including 6 homozygotes (https://gnomad.broadinstitute.org/variant/10-94545923-T-C?dataset=gnomad_r3). This variant is present in ClinVar (Variation ID:716400). Evolutionary conservation and computational predictive tools for this variant are unclear. This variant alters the initiation codon (Methionine), potentially resulting in loss of the protein. However, the presence of this variant in controls, particularly homozygotes argues against a pathogenic impact. In summary, data on this variant suggests that this variant does not cause disease but requires further evidence. Therefore, this variant is classified as likely benign. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Benign
T
BayesDel_noAF
Uncertain
CADD
Uncertain
DANN
Benign
DEOGEN2
Benign
T;T;.;.
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Benign
N
LIST_S2
Uncertain
D;D;D;D
MetaRNN
Benign
T;T;T;T
MetaSVM
Uncertain
D
PROVEAN
Benign
.;N;N;N
REVEL
Uncertain
Sift
Pathogenic
.;D;D;D
Sift4G
Pathogenic
D;D;D;D
Polyphen
0.72, 0.95
.;P;.;P
Vest4
MVP
ClinPred
T
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at